Table 3.
Single clinician | ||||||||
AD | VaD | DLB | Mixed | FTD | Other | Total | ||
Consensus conference | AD | 134 (40/94) | 2 (1/1) | 3 (0/3) | 11 (4/7) | 5 (1/4) | 4 (2/2) | 159 (48/111) |
VaD | 0 | 25 (7/18) | 0 | 3 (2/1) | 0 | 3 (3/0) | 31 (12/19) | |
DLB | 1 (0/1) | 1 (0/1) | 19 (6/13) | 1 (1/0) | 1 (0/1) | 1 (0/1) | 24 (7/17) | |
Mixed | 2 (0/2) | 2 (0/2) | 0 | 17 (3/14) | 0 | 1 (0/1) | 22 (3/19) | |
FTD | 5 (2/3) | 0 | 0 | 1 (1/0) | 16 (0/16) | 2 (0/2) | 24 (3/21) | |
Other | 4 (3/1) | 5 (4/1) | 3 (0/3) | 0 | 7 (1/6) | 26 (12/14) | 45 (20/25) | |
Total | 146 (45/101) | 35 (12/23) | 25 (6/19) | 33 (11/22) | 29 (2/27) | 37 (17/20) | 305 (93/212) |
Confusion matrix presenting baseline etiological diagnosis agreement. Data presented as total (MCI/dementia). AD, Alzheimer’s disease; VaD, vascular dementia; DLB, dementia with Lewy bodies; Mixed, mixed dementia with AD and VaD; FTD, frontotemporal dementia; Other, Other dementia.